Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Iron
Drug ID BADD_D01197
Description A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.
Indications and Usage Used in preventing and treating iron-deficiency anemia.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB01592
KEGG ID Not Available
MeSH ID D007501
PubChem ID 23925
TTD Drug ID D0Y3TM
NDC Product Code 0220-2054; 62106-5042; 68428-383; 64117-791; 0220-2051; 0164-1152
UNII E1UOL152H7
Synonyms Iron | Iron-56 | Iron 56
Chemical Information
Molecular Formula Fe
CAS Registry Number 7439-89-6
SMILES [Fe]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Ileal ulcer07.04.06.008--
Impaired gastric emptying07.02.02.0040.000453%
Impaired healing08.03.02.001--Not Available
Incontinence20.02.02.004; 17.05.01.006; 07.01.06.011--Not Available
Infection11.01.08.002--Not Available
Influenza like illness08.01.03.0100.000997%
Injection site bruising24.07.06.017; 23.03.11.015; 12.07.03.042; 08.02.03.042--Not Available
Injection site erythema12.07.03.001; 08.02.03.001; 23.03.06.015--Not Available
Injection site extravasation12.07.03.002; 08.02.03.002--Not Available
Injection site haematoma24.07.01.009; 12.07.03.004; 08.02.03.004--Not Available
Injection site haemorrhage08.02.03.005; 24.07.01.010; 12.07.03.0050.001224%Not Available
Injection site mass12.07.03.010; 08.02.03.0090.001224%Not Available
Injection site pain12.07.03.011; 08.02.03.0100.002992%Not Available
Injection site pruritus12.07.03.014; 08.02.03.013; 23.03.12.007--Not Available
Injection site rash12.07.03.032; 23.03.13.010; 08.02.03.032--Not Available
Injection site reaction12.07.03.015; 08.02.03.014--
Injection site urticaria23.04.02.003; 12.07.03.029; 10.01.06.003; 08.02.03.029--Not Available
Insomnia19.02.01.002; 17.15.03.0020.001224%
Intestinal obstruction07.13.01.0020.000453%Not Available
Intestinal perforation07.04.06.0020.000453%Not Available
Intestinal stenosis07.13.01.0030.000453%Not Available
Iron deficiency14.13.02.0020.000453%Not Available
Iron deficiency anaemia14.13.02.001; 01.03.01.0020.001360%Not Available
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.0040.000453%Not Available
Joint stiffness15.01.02.003--Not Available
Joint swelling15.01.02.0040.000453%Not Available
Lacrimation increased06.08.02.004--
Laryngeal oedema23.04.01.005; 10.01.05.003; 22.04.02.0010.000453%
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.0080.000453%
Leukocytosis01.02.01.002--
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 14 Pages